The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of new non-executive director

14 May 2020 08:31

RNS Number : 8994M
Iconic Labs PLC
14 May 2020
 

 

Iconic Labs PLC

14th May 2020

Iconic Labs Plc ("Iconic Labs" or the "Company")

Appointment of new non-executive director

 

· Respected digital media specialist

· Top tier experience: Bloomberg / eBay / Fremantle

· Adviser to leading distributors, publishers and producers

 

Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, is pleased to announce the appointment of Katharine Lewis a non-executive director.

Katharine Lewis has more than 20 years' experience in senior roles in the media and technology industries, across the UK, US and Asia.

 

After starting as a journalist, Katharine was hired into a management role at Bloomberg in New York. Following considerable success there, Katharine worked at several digital media start-ups, including eBay. Katharine then joined Fremantle, one of the world's largest TV and entertainment companies which produces over 450 TV programmes per year with in excess of 12,000 hours of programming. Fremantle's productions have achieved over 1 billion views on You Tube. 

 

At Freemantle, Katharine worked initially as Deputy Head of Fremantle Media Ventures, and ultimately became Senior Vice President Strategy and Operations for Fremantle Digital and Branded Entertainment worldwide.

 

In 2016 Katharine left Fremantle to create FutureSmartMedia, a media consulting business which advises some of the industry's leading content distributors, publishers and producers. Katharine has an MBA from INSEAD business school, sits on several boards, and supports the young people's charity The British Youth Council. 

 

John Quinlan, Chief Executive Officer of Iconic Labs, said: "The role of non-executive directors is very important both in helping Iconic Labs to grow, and ensuring that there is proper oversight of the company and its management responsibilities, controls and performance. We are delighted that Katharine has agreed to join the board, as not only will her seniority and experience help us further improve our corporate governance, but we will also be able to benefit from her considerable sector experience and contacts. Few others can combine having been at the hard end of both traditional and new digital media with leaders in the fields. She also understands both technology and the process of taking start-ups and early stage companies and helping them grow into serious businesses. We look forward to working with her to help Iconic Labs become one of the leaders in this very exciting field."

 

Katharine Lewis said: "Having watched what the team achieved at UNILAD, I am very excited to work with them at Iconic Labs to help them execute on their very exciting plans. In my view, the role and reach of digital media is still at an early stage compared to what it is capable of achieving, and that presents a rare opportunity for the emergent players in the sector. I look forward to helping Iconic Labs becoming one of the leaders in this very exciting field." https://uk.linkedin.com/in/katharinealewis

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Damon Heath Shard Capital Partners LLP Tel: +44 (0) 20 7186 9950

Iconic Labs ir@iconiclabs.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGRGDUCDBDGGS
Date   Source Headline
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023
24th Oct 20235:31 pmRNSChange of Auditor
17th Oct 20237:51 amRNSConversion of Securities
13th Oct 202311:32 amRNSAnnouncement of the Completion of CVA
13th Oct 202311:30 amRNSConversion of Securities
29th Sep 20238:01 amRNSTotal Voting Rights
22nd Sep 20239:40 amRNSConversion of Securities
18th Sep 20236:27 pmRNSConversion of Notes – Replacement
18th Sep 20237:37 amRNSConversion of Securities
12th Sep 20238:45 amRNSStatement re CVA
4th Sep 202312:02 pmRNSConversion of Securities
31st Aug 20237:21 amRNSTotal Voting Rights
25th Aug 20234:49 pmRNSResult of AGM
18th Aug 20237:51 amRNSConversion of Securities
14th Aug 20237:59 amRNSIssue of Debt
8th Aug 20232:58 pmRNSPublication of a Prospectus
4th Aug 20234:19 pmRNSNotice of AGM
30th Jun 20239:12 amRNSTotal Voting Rights
2nd Jun 20231:20 pmRNSIssue of Equity
28th Apr 202310:35 amRNSTotal Voting Rights
12th Apr 20238:13 amRNSConversion of Securities
31st Mar 20233:11 pmRNSTotal Voting Rights
31st Mar 20231:59 pmRNSHalf-year Report
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20237:42 amRNSConversion of Securities
27th Mar 202311:05 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
22nd Mar 202311:48 amRNSSubscription of Convertible Notes
21st Mar 202311:05 amRNSSecond Price Monitoring Extn
21st Mar 202311:00 amRNSPrice Monitoring Extension
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
20th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.